CTSL and triple-negative breast carcinoma: The authors further confirmed the nuclear localisation of CtsL in triple negative breast cancer patients, confirming a negative correlation between the levels of nuclear CtsL and TP53BP1, further reinforcing the nuclear activity of CtsL.